Skip to main content
logo
Enimmune Corporation (TPEX:6564)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.15
-0.45 (-2.42%)
Apr 20, 2026, 12:55 PM CST

Enimmune Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-164.35-157.55-223.74-247.96-47.25
Depreciation & Amortization
9.077.447.68.28.49
Other Amortization
-0.150.150.150.14
Stock-Based Compensation
1.753.033.692.27-
Provision & Write-off of Bad Debts
-1.58-0.150.174.920.07
Other Operating Activities
-17.359.31-13.89-19.330.02
Change in Accounts Receivable
-0.02-0.45-7.4717.461.19
Change in Inventory
1.11-6.6444.78-8.48-9.79
Change in Accounts Payable
-0.1-15.1714.09-6.39-6.75
Change in Unearned Revenue
----1.72
Change in Other Net Operating Assets
28.216.2436.548.53-19.38
Operating Cash Flow
-143.25-143.78-138.13-200.64-71.55
Capital Expenditures
-4.18-0.47--0.35-2.98
Sale (Purchase) of Intangibles
-----0.43
Investment in Securities
--88123.4993.5
Other Investing Activities
-21.57-3.17-0.14-23.210.01
Investing Cash Flow
-25.75-3.6487.8699.9490.1
Short-Term Debt Issued
25602020-
Long-Term Debt Issued
38.566.11---
Total Debt Issued
63.5666.112020-
Long-Term Debt Repaid
-10.35-4.06-3.97-3.95-3.94
Net Debt Issued (Repaid)
53.2162.0516.0316.05-3.94
Issuance of Common Stock
-202.04-220.35-
Other Financing Activities
-156.31--144.68-
Financing Cash Flow
-103.1264.0916.03381.08-3.94
Foreign Exchange Rate Adjustments
-10.428.34-0.04-4.59-
Net Cash Flow
-282.52125.01-34.28275.7914.61
Free Cash Flow
-147.43-144.25-138.13-200.98-74.53
Free Cash Flow Margin
-305.91%-361.39%-317.59%-106.67%-67.86%
Free Cash Flow Per Share
-2.04-2.02-2.10-3.15-1.24
Cash Interest Paid
-2.120.920.280.21
Levered Free Cash Flow
-88.01-74.54-53.27-127.9-61.94
Unlevered Free Cash Flow
-85.5-73.16-52.65-127.7-61.79
Change in Working Capital
29.2-6.0287.951.12-33.01
Source: S&P Global Market Intelligence. Standard template. Financial Sources.